Bronchoscopic diagnosis of peripheral pulmonary lung cancer employing sedation with fentanyl and midazolam

Sedation with fentanyl and midazolam during bronchoscopic examination is commonly employed by pulmonary physicians in the USA and Europe. We assessed the efficacy of such sedation in the bronchoscopic diagnosis of peripheral lung cancer. We retrospectively evaluated data from 102 patients who underw...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Respiratory investigation 2017-09, Vol.55 (5), p.314-317
Hauptverfasser: Minami, Daisuke, Nakasuka, Takamasa, Ando, Chihiro, Iwamoto, MD, Yoshitaka, Sato, Ken, Fujiwara, Keiichi, Shibayama, Takuo, Yonei, MD, PhD, Toshirou, Sato, Toshio
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 317
container_issue 5
container_start_page 314
container_title Respiratory investigation
container_volume 55
creator Minami, Daisuke
Nakasuka, Takamasa
Ando, Chihiro
Iwamoto, MD, Yoshitaka
Sato, Ken
Fujiwara, Keiichi
Shibayama, Takuo
Yonei, MD, PhD, Toshirou
Sato, Toshio
description Sedation with fentanyl and midazolam during bronchoscopic examination is commonly employed by pulmonary physicians in the USA and Europe. We assessed the efficacy of such sedation in the bronchoscopic diagnosis of peripheral lung cancer. We retrospectively evaluated data from 102 patients who underwent transbronchial biopsies (TBB) for diagnosis of peripheral lung cancer. Bronchoscopies with and without fentanyl were performed in 61 (group A) and 41 (group B) patients, respectively. Midazolam was administered to all patients. Medical records were retrieved, and between-group comparisons were made using unpaired Student's t-tests. The mean fentanyl dose was 49.5 μg (range: 10–100 μg), and midazolam doses in groups A and B were 4.29mg (range: 1–14mg) and 5.54mg (range: 1–12mg), respectively. Diagnostic histological specimens were obtained from 75.4% and 65.8% of group A and B patients, respectively (P = 0.30). The diagnostic sensitivities for lung cancer, via at least one of TBB, cytological brushing, or bronchial washing, in groups A and B were 88.5% and 70.4%, respectively (P = 0.035). Moreover, lesion diagnostic sensitivities, via at least one of TBB, cytological brushing, and bronchial washing, in groups A and B were 98.1% and 68.0%, respectively (P = 0.01). Fentanyl and midazolam sedation during bronchoscopy facilitated the diagnosis of peripheral pulmonary lung cancers.
doi_str_mv 10.1016/j.resinv.2017.07.001
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1942708794</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2212534517300801</els_id><sourcerecordid>1942708794</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-acebd2858fdae1ecb9f2b2387b314f7093d829d2b2f7741289b2aae78cf43fa43</originalsourceid><addsrcrecordid>eNp9kE1LBDEMhosoKuo_EOnRy65tZ2bbuQgqfoHgRc-l06Zul047tjPK-uvtsurREEgIbxLeB6FTSuaU0MXFap4gu_AxZ4TyOSlJ6A46ZIyyWVM11e5fXzcH6CTnFSmxaFhNF_vogIm2ZkLwQ7S6TjHoZcw6Dk5j49RbiNllHC0eILlhCUl5PEy-j0GlNfZTeMNaBQ0JQz_4uHZlkMGo0cWAP924xBbCqMLaYxUM7p1RX9Gr_hjtWeUznPzUI_R6d_ty8zB7er5_vLl6mulKLMaZ0tAZJhphjQIKumst61gleFfR2nLSVkaw1pSZ5bymxUrHlAIutK0rq-rqCJ1v7w4pvk-QR9m7rMF7FSBOWdLinRPB24203kp1ijknsHJIri82JSVyA1qu5Ba03ICWpCShZe3s58PU9WD-ln6xFsHlVgDF54eDJLN2UJgZl0CP0kT3_4dvobKT4A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1942708794</pqid></control><display><type>article</type><title>Bronchoscopic diagnosis of peripheral pulmonary lung cancer employing sedation with fentanyl and midazolam</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Minami, Daisuke ; Nakasuka, Takamasa ; Ando, Chihiro ; Iwamoto, MD, Yoshitaka ; Sato, Ken ; Fujiwara, Keiichi ; Shibayama, Takuo ; Yonei, MD, PhD, Toshirou ; Sato, Toshio</creator><creatorcontrib>Minami, Daisuke ; Nakasuka, Takamasa ; Ando, Chihiro ; Iwamoto, MD, Yoshitaka ; Sato, Ken ; Fujiwara, Keiichi ; Shibayama, Takuo ; Yonei, MD, PhD, Toshirou ; Sato, Toshio</creatorcontrib><description>Sedation with fentanyl and midazolam during bronchoscopic examination is commonly employed by pulmonary physicians in the USA and Europe. We assessed the efficacy of such sedation in the bronchoscopic diagnosis of peripheral lung cancer. We retrospectively evaluated data from 102 patients who underwent transbronchial biopsies (TBB) for diagnosis of peripheral lung cancer. Bronchoscopies with and without fentanyl were performed in 61 (group A) and 41 (group B) patients, respectively. Midazolam was administered to all patients. Medical records were retrieved, and between-group comparisons were made using unpaired Student's t-tests. The mean fentanyl dose was 49.5 μg (range: 10–100 μg), and midazolam doses in groups A and B were 4.29mg (range: 1–14mg) and 5.54mg (range: 1–12mg), respectively. Diagnostic histological specimens were obtained from 75.4% and 65.8% of group A and B patients, respectively (P = 0.30). The diagnostic sensitivities for lung cancer, via at least one of TBB, cytological brushing, or bronchial washing, in groups A and B were 88.5% and 70.4%, respectively (P = 0.035). Moreover, lesion diagnostic sensitivities, via at least one of TBB, cytological brushing, and bronchial washing, in groups A and B were 98.1% and 68.0%, respectively (P = 0.01). Fentanyl and midazolam sedation during bronchoscopy facilitated the diagnosis of peripheral pulmonary lung cancers.</description><identifier>ISSN: 2212-5345</identifier><identifier>EISSN: 2212-5353</identifier><identifier>DOI: 10.1016/j.resinv.2017.07.001</identifier><identifier>PMID: 28942887</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Adenocarcinoma - diagnosis ; Adenocarcinoma - pathology ; Aged ; Aged, 80 and over ; Biopsy - methods ; Bronchoscopy ; Bronchoscopy - methods ; Carcinoma, Squamous Cell - diagnosis ; Carcinoma, Squamous Cell - pathology ; Conscious Sedation - methods ; Female ; Fentanyl ; Fentanyl - administration &amp; dosage ; Humans ; Hypnotics and Sedatives - administration &amp; dosage ; Lung cancer ; Lung Neoplasms - diagnosis ; Lung Neoplasms - pathology ; Male ; Midazolam ; Midazolam - administration &amp; dosage ; Middle Aged ; Retrospective Studies ; Sedation ; Sensitivity and Specificity ; Small Cell Lung Carcinoma - diagnosis ; Small Cell Lung Carcinoma - pathology</subject><ispartof>Respiratory investigation, 2017-09, Vol.55 (5), p.314-317</ispartof><rights>2017 The Japanese Respiratory Society</rights><rights>Copyright © 2017 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c386t-acebd2858fdae1ecb9f2b2387b314f7093d829d2b2f7741289b2aae78cf43fa43</citedby><cites>FETCH-LOGICAL-c386t-acebd2858fdae1ecb9f2b2387b314f7093d829d2b2f7741289b2aae78cf43fa43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28942887$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Minami, Daisuke</creatorcontrib><creatorcontrib>Nakasuka, Takamasa</creatorcontrib><creatorcontrib>Ando, Chihiro</creatorcontrib><creatorcontrib>Iwamoto, MD, Yoshitaka</creatorcontrib><creatorcontrib>Sato, Ken</creatorcontrib><creatorcontrib>Fujiwara, Keiichi</creatorcontrib><creatorcontrib>Shibayama, Takuo</creatorcontrib><creatorcontrib>Yonei, MD, PhD, Toshirou</creatorcontrib><creatorcontrib>Sato, Toshio</creatorcontrib><title>Bronchoscopic diagnosis of peripheral pulmonary lung cancer employing sedation with fentanyl and midazolam</title><title>Respiratory investigation</title><addtitle>Respir Investig</addtitle><description>Sedation with fentanyl and midazolam during bronchoscopic examination is commonly employed by pulmonary physicians in the USA and Europe. We assessed the efficacy of such sedation in the bronchoscopic diagnosis of peripheral lung cancer. We retrospectively evaluated data from 102 patients who underwent transbronchial biopsies (TBB) for diagnosis of peripheral lung cancer. Bronchoscopies with and without fentanyl were performed in 61 (group A) and 41 (group B) patients, respectively. Midazolam was administered to all patients. Medical records were retrieved, and between-group comparisons were made using unpaired Student's t-tests. The mean fentanyl dose was 49.5 μg (range: 10–100 μg), and midazolam doses in groups A and B were 4.29mg (range: 1–14mg) and 5.54mg (range: 1–12mg), respectively. Diagnostic histological specimens were obtained from 75.4% and 65.8% of group A and B patients, respectively (P = 0.30). The diagnostic sensitivities for lung cancer, via at least one of TBB, cytological brushing, or bronchial washing, in groups A and B were 88.5% and 70.4%, respectively (P = 0.035). Moreover, lesion diagnostic sensitivities, via at least one of TBB, cytological brushing, and bronchial washing, in groups A and B were 98.1% and 68.0%, respectively (P = 0.01). Fentanyl and midazolam sedation during bronchoscopy facilitated the diagnosis of peripheral pulmonary lung cancers.</description><subject>Adenocarcinoma - diagnosis</subject><subject>Adenocarcinoma - pathology</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biopsy - methods</subject><subject>Bronchoscopy</subject><subject>Bronchoscopy - methods</subject><subject>Carcinoma, Squamous Cell - diagnosis</subject><subject>Carcinoma, Squamous Cell - pathology</subject><subject>Conscious Sedation - methods</subject><subject>Female</subject><subject>Fentanyl</subject><subject>Fentanyl - administration &amp; dosage</subject><subject>Humans</subject><subject>Hypnotics and Sedatives - administration &amp; dosage</subject><subject>Lung cancer</subject><subject>Lung Neoplasms - diagnosis</subject><subject>Lung Neoplasms - pathology</subject><subject>Male</subject><subject>Midazolam</subject><subject>Midazolam - administration &amp; dosage</subject><subject>Middle Aged</subject><subject>Retrospective Studies</subject><subject>Sedation</subject><subject>Sensitivity and Specificity</subject><subject>Small Cell Lung Carcinoma - diagnosis</subject><subject>Small Cell Lung Carcinoma - pathology</subject><issn>2212-5345</issn><issn>2212-5353</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LBDEMhosoKuo_EOnRy65tZ2bbuQgqfoHgRc-l06Zul047tjPK-uvtsurREEgIbxLeB6FTSuaU0MXFap4gu_AxZ4TyOSlJ6A46ZIyyWVM11e5fXzcH6CTnFSmxaFhNF_vogIm2ZkLwQ7S6TjHoZcw6Dk5j49RbiNllHC0eILlhCUl5PEy-j0GlNfZTeMNaBQ0JQz_4uHZlkMGo0cWAP924xBbCqMLaYxUM7p1RX9Gr_hjtWeUznPzUI_R6d_ty8zB7er5_vLl6mulKLMaZ0tAZJhphjQIKumst61gleFfR2nLSVkaw1pSZ5bymxUrHlAIutK0rq-rqCJ1v7w4pvk-QR9m7rMF7FSBOWdLinRPB24203kp1ijknsHJIri82JSVyA1qu5Ba03ICWpCShZe3s58PU9WD-ln6xFsHlVgDF54eDJLN2UJgZl0CP0kT3_4dvobKT4A</recordid><startdate>201709</startdate><enddate>201709</enddate><creator>Minami, Daisuke</creator><creator>Nakasuka, Takamasa</creator><creator>Ando, Chihiro</creator><creator>Iwamoto, MD, Yoshitaka</creator><creator>Sato, Ken</creator><creator>Fujiwara, Keiichi</creator><creator>Shibayama, Takuo</creator><creator>Yonei, MD, PhD, Toshirou</creator><creator>Sato, Toshio</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201709</creationdate><title>Bronchoscopic diagnosis of peripheral pulmonary lung cancer employing sedation with fentanyl and midazolam</title><author>Minami, Daisuke ; Nakasuka, Takamasa ; Ando, Chihiro ; Iwamoto, MD, Yoshitaka ; Sato, Ken ; Fujiwara, Keiichi ; Shibayama, Takuo ; Yonei, MD, PhD, Toshirou ; Sato, Toshio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-acebd2858fdae1ecb9f2b2387b314f7093d829d2b2f7741289b2aae78cf43fa43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adenocarcinoma - diagnosis</topic><topic>Adenocarcinoma - pathology</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biopsy - methods</topic><topic>Bronchoscopy</topic><topic>Bronchoscopy - methods</topic><topic>Carcinoma, Squamous Cell - diagnosis</topic><topic>Carcinoma, Squamous Cell - pathology</topic><topic>Conscious Sedation - methods</topic><topic>Female</topic><topic>Fentanyl</topic><topic>Fentanyl - administration &amp; dosage</topic><topic>Humans</topic><topic>Hypnotics and Sedatives - administration &amp; dosage</topic><topic>Lung cancer</topic><topic>Lung Neoplasms - diagnosis</topic><topic>Lung Neoplasms - pathology</topic><topic>Male</topic><topic>Midazolam</topic><topic>Midazolam - administration &amp; dosage</topic><topic>Middle Aged</topic><topic>Retrospective Studies</topic><topic>Sedation</topic><topic>Sensitivity and Specificity</topic><topic>Small Cell Lung Carcinoma - diagnosis</topic><topic>Small Cell Lung Carcinoma - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Minami, Daisuke</creatorcontrib><creatorcontrib>Nakasuka, Takamasa</creatorcontrib><creatorcontrib>Ando, Chihiro</creatorcontrib><creatorcontrib>Iwamoto, MD, Yoshitaka</creatorcontrib><creatorcontrib>Sato, Ken</creatorcontrib><creatorcontrib>Fujiwara, Keiichi</creatorcontrib><creatorcontrib>Shibayama, Takuo</creatorcontrib><creatorcontrib>Yonei, MD, PhD, Toshirou</creatorcontrib><creatorcontrib>Sato, Toshio</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Respiratory investigation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Minami, Daisuke</au><au>Nakasuka, Takamasa</au><au>Ando, Chihiro</au><au>Iwamoto, MD, Yoshitaka</au><au>Sato, Ken</au><au>Fujiwara, Keiichi</au><au>Shibayama, Takuo</au><au>Yonei, MD, PhD, Toshirou</au><au>Sato, Toshio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bronchoscopic diagnosis of peripheral pulmonary lung cancer employing sedation with fentanyl and midazolam</atitle><jtitle>Respiratory investigation</jtitle><addtitle>Respir Investig</addtitle><date>2017-09</date><risdate>2017</risdate><volume>55</volume><issue>5</issue><spage>314</spage><epage>317</epage><pages>314-317</pages><issn>2212-5345</issn><eissn>2212-5353</eissn><abstract>Sedation with fentanyl and midazolam during bronchoscopic examination is commonly employed by pulmonary physicians in the USA and Europe. We assessed the efficacy of such sedation in the bronchoscopic diagnosis of peripheral lung cancer. We retrospectively evaluated data from 102 patients who underwent transbronchial biopsies (TBB) for diagnosis of peripheral lung cancer. Bronchoscopies with and without fentanyl were performed in 61 (group A) and 41 (group B) patients, respectively. Midazolam was administered to all patients. Medical records were retrieved, and between-group comparisons were made using unpaired Student's t-tests. The mean fentanyl dose was 49.5 μg (range: 10–100 μg), and midazolam doses in groups A and B were 4.29mg (range: 1–14mg) and 5.54mg (range: 1–12mg), respectively. Diagnostic histological specimens were obtained from 75.4% and 65.8% of group A and B patients, respectively (P = 0.30). The diagnostic sensitivities for lung cancer, via at least one of TBB, cytological brushing, or bronchial washing, in groups A and B were 88.5% and 70.4%, respectively (P = 0.035). Moreover, lesion diagnostic sensitivities, via at least one of TBB, cytological brushing, and bronchial washing, in groups A and B were 98.1% and 68.0%, respectively (P = 0.01). Fentanyl and midazolam sedation during bronchoscopy facilitated the diagnosis of peripheral pulmonary lung cancers.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>28942887</pmid><doi>10.1016/j.resinv.2017.07.001</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 2212-5345
ispartof Respiratory investigation, 2017-09, Vol.55 (5), p.314-317
issn 2212-5345
2212-5353
language eng
recordid cdi_proquest_miscellaneous_1942708794
source MEDLINE; Alma/SFX Local Collection
subjects Adenocarcinoma - diagnosis
Adenocarcinoma - pathology
Aged
Aged, 80 and over
Biopsy - methods
Bronchoscopy
Bronchoscopy - methods
Carcinoma, Squamous Cell - diagnosis
Carcinoma, Squamous Cell - pathology
Conscious Sedation - methods
Female
Fentanyl
Fentanyl - administration & dosage
Humans
Hypnotics and Sedatives - administration & dosage
Lung cancer
Lung Neoplasms - diagnosis
Lung Neoplasms - pathology
Male
Midazolam
Midazolam - administration & dosage
Middle Aged
Retrospective Studies
Sedation
Sensitivity and Specificity
Small Cell Lung Carcinoma - diagnosis
Small Cell Lung Carcinoma - pathology
title Bronchoscopic diagnosis of peripheral pulmonary lung cancer employing sedation with fentanyl and midazolam
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T21%3A02%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bronchoscopic%20diagnosis%20of%20peripheral%20pulmonary%20lung%20cancer%20employing%20sedation%20with%20fentanyl%20and%20midazolam&rft.jtitle=Respiratory%20investigation&rft.au=Minami,%20Daisuke&rft.date=2017-09&rft.volume=55&rft.issue=5&rft.spage=314&rft.epage=317&rft.pages=314-317&rft.issn=2212-5345&rft.eissn=2212-5353&rft_id=info:doi/10.1016/j.resinv.2017.07.001&rft_dat=%3Cproquest_cross%3E1942708794%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1942708794&rft_id=info:pmid/28942887&rft_els_id=S2212534517300801&rfr_iscdi=true